First patient with metastatic prostate cancer to receive 2 doses of Cu-67 SAR-bisPSMA achieves undetectable PSA level

HIGHLIGHTS Undetectable levels of Prostate Specific Antigen (PSA) have been reported from…

Binance Pilots Banking Triparty Agreement to Help Institutional Investors to Manage Counterparty Exposure

This first-in-crypto solution replicates traditional finance framework enabling institutions to fulfill risk…

Xuzhou, Jiangsu: New intelligent power distribution grid to help distributed photovoltaic development

XUZHOU, China, Nov. 30, 2023 /PRNewswire/ — In recent years, distributed photovoltaic…

Bushu Pharma Recognized with Frost & Sullivan's 2023 Japan Customer Value Leadership Award for Offering Advanced Pharmaceutical Manufacturing and Robust Supply Chain Solutions

Bushu Pharma produces high-quality pharmaceutical and medical devices with sophisticated quality control…

Argon Medical Launches Kodiak™ Dual Port Coaxial Introducer Kit for Complex Vascular Procedures

PLANO, Texas, Nov. 30, 2023 /PRNewswire/ — Argon Medical Devices, a leading…

Registrational Phase III CLARIFY trial in prostate cancer commences

SYDNEY, Nov. 30, 2023 /PRNewswire/ — Clarity Pharmaceuticals (ASX: CU6) ("Clarity"), a…

Lunit to Advance Singapore's Healthcare System with AI-powered Solution for Medical Imaging

Lunit INSIGHT CXR is piloted at Singapore General Hospital and Changi General…